Long-term unsupervised mobility assessment in movement disorders

Elke Warmerdam, Jeffrey M. Hausdorff, Arash Atrsaei, Yuhan Zhou, Anat Mirelman, Kamiar Aminian, Alberto J. Espay, Clint Hansen, Luc J.W. Evers, Andreas Keller, Claudine Lamoth, Andrea Pilotto, Lynn Rochester, Gerhard Schmidt, Bastiaan R. Bloem, Walter Maetzler

Research output: Contribution to journalReview articlepeer-review

189 Scopus citations

Abstract

Mobile health technologies (wearable, portable, body-fixed sensors, or domestic-integrated devices) that quantify mobility in unsupervised, daily living environments are emerging as complementary clinical assessments. Data collected in these ecologically valid, patient-relevant settings can overcome limitations of conventional clinical assessments, as they capture fluctuating and rare events. These data could support clinical decision making and could also serve as outcomes in clinical trials. However, studies that directly compared assessments made in unsupervised and supervised (eg, in the laboratory or hospital) settings point to large disparities, even in the same parameters of mobility. These differences appear to be affected by psychological, physiological, cognitive, environmental, and technical factors, and by the types of mobilities and diagnoses assessed. To facilitate the successful adaptation of the unsupervised assessment of mobility into clinical practice and clinical trials, clinicians and researchers should consider these disparities and the multiple factors that contribute to them.

Original languageEnglish
Pages (from-to)462-470
Number of pages9
JournalThe Lancet Neurology
Volume19
Issue number5
DOIs
StatePublished - 1 May 2020
Externally publishedYes

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Long-term unsupervised mobility assessment in movement disorders'. Together they form a unique fingerprint.

Cite this